Retatrutide

Retatrutide is a “triple-agonist” that mimics three hormones (GLP-1, GIP, and glucagon) to suppress appetite and boost metabolism. Clinical trials have shown average weight loss of up to 28–30%. Not yet FDA-approved.

For laboratory research use only. Not for human or veterinary use.

Fulfillment note: 10 mg, 15 mg, and 20 mg selections are supplied as multiple 5 mg vials.

Volume pricing: Pricing goes down when you order more; eligible volume discounts are shown on this page and applied automatically in cart.